Regulierung der nationalen Pharmamärkte in der Europäischen Gemeinschaft

Manfred Erbsland and Angelika Mehnert

No 92-13, ZEW Discussion Papers from ZEW - Leibniz Centre for European Economic Research

Abstract: In this paper we give an overview of government regulations in the national drug markets of the European Community. We describe the admission of new medicines to the market, the organisation of the distribution system, the control of pharmaceutical prices, and the patient copayment schemes for out-of-hospital prescriptions.

Date: 1992
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/29381/1/256795355.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:zewdip:9213

Access Statistics for this paper

More papers in ZEW Discussion Papers from ZEW - Leibniz Centre for European Economic Research Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().